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A B S T R A C T
Background
Cause-specific mortality statistics remain scarce for the majority of low-income countries,
where the highest disease burdens are experienced. Neither facility-based information systems
nor vital registration provide adequate or representative data. The expansion of sample vital
registration with verbal autopsy procedures represents the most promising interim solution for
this problem. The development and validation of core verbal autopsy forms and suitable
coding and tabulation procedures are an essential first step to extending the benefits of this
method.
Methods and Findings
Core forms for peri- and neonatal, child, and adult deaths were developed and revised over
12 y through a project of the Tanzanian Ministry of Health and were applied to over 50,000
deaths. The contents of the core forms draw upon and are generally comparable with
previously proposed verbal autopsy procedures. The core forms and coding procedures based
on the International Statistical Classification of Diseases (ICD) were further adapted for use in
China. These forms, the ICD tabulation list, the summary validation protocol, and the summary
validation results from Tanzania and China are presented here.
Conclusions
The procedures are capable of providing reasonable mortality estimates as adjudged against
stated performance criteria for several common causes of death in two countries with radically
different cause structures of mortality. However, the specific causes for which the procedures
perform well varied between the two settings because of differences in the underlying
prevalence of the main causes of death. These differences serve to emphasize the need to
undertake validation studies of verbal autopsy procedures when they are applied in new
epidemiological settings.
The Editors’ Summary of this article follows the references.
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Introduction
Globally, only about a third of all deaths are registered with
age, sex, and cause [1]. The vast majority of these are in
developed countries. In sub-Saharan Africa, where premature
mortality accounts for about 80% of the total burden of
disease [2], the need to remedy this situation is urgent. What
is known about causes of death in these areas comes primarily
from demographic surveillance sites and is largely limited to
causes of death among children [3–6]. While more is known
about child mortality than that of adults, knowledge remains
patchy for neonatal and perinatal mortality [7].
In a 2003 address to the World Health Organization (WHO)
staff, Director General Jong-Wook Lee succinctly highlighted
the urgency of improving knowledge about vital events: ‘‘To
make people count, we first need to be able to count people’’
[8]. The WHO has likened the continued lack of quality health
information in lower-income countries, including data on
vital events, to a ‘‘gathering storm’’ [9]. The crisis is being
precipitated by the rapid escalation in national data demands
and in reporting requirements for international initiatives,
many of which require summary measures of survival and/or
cause-specific mortality as indicators of program impact.
Improving the monitoring of vital events, and generating
representative mortality statistics in lower-income countries
in particular, will require new techniques, new technologies,
and new thinking about sustainable, representative, and
reliable systems for registering deaths and determining causes
[10].
Sample or sentinel mortality surveillance using stand-
ardized ‘‘verbal autopsy’’ (VA) procedures represents a viable
mid- or long-term strategy for improving mortality informa-
tion [10]. A VA is an interview administered to caregivers or
family members after a death occurs. A wide range of
interview instruments and cause-of-death attribution proce-
dures have been developed for this purpose [11–18]. Although
VA is a limited tool [19], the procedure has demonstrated the
ability to produce valid estimates of the mortality cause
structure in many settings [14,20–25]. Some assessments of
the validity and cross-comparability of VA-derived mortality
estimates for child mortality have also been conducted [4–6].
VA has been applied in numerous countries, among children
and adults, and for the purposes of both exploring specific
causes of death in research projects and developing an overall
description of the mortality structure at the community or
population level. The WHO and the United Nations Child-
ren’s Fund have called for the expanded use of the technique
to monitor child mortality for at least a decade [26].
This article presents a proposed set of core VA procedures
and the summary results of a two-country validation study
conducted in Tanzania and China. These procedures are
proposed for adaptation to a variety of settings, particularly
in the context of sample or sentinel vital registration.
Experiences from India [27], China [28], and Tanzania
[29,30] have shown how information generated through
community-based mortality surveillance using VA can influ-
ence health policy, practice, monitoring, and evaluation.
Generating data from VA procedures follows a simple,
stepwise process. First, deaths are registered using some form
of active, community-based reporting system. Second, VA
interviews are obtained by trained interviewers who visit the
households of the deceased within a specified period after the
death. Third, physician certifiers use these completed VA
interview forms to assign a specific cause of death, and write
death certificates according to protocols based on the
International Statistical Classification of Diseases and Related Health
Problems, 10th revision (ICD-10) [31–33]. Lastly, mortality data
are tabulated on a periodic basis and fed into routine
reporting, planning, and monitoring processes and are used
to analyze mortality structures, levels, and trends.
The ultimate impact of mortality surveillance will hinge
upon the validity, comparability, and consistency of tools and
methods used to obtain the ‘‘raw’’ data from representative
sample or sentinel populations. In order to contribute to the
expanded use of VA in sample and sentinel registration, as
well as in research, this paper proposes a core set of VA
procedures that have been validated in China and Tanzania.
Where relevant, we have compared these procedures with
those used in other settings.
Methods
Between 1992 and 2004, the VA procedures presented here
were developed as part of a long-term national system of
sentinel demographic surveillance in Tanzania. The forms,
coding methods, and mortality surveillance activities were
integrated into the routine functions of local health author-
ities in Tanzania [34–36] and were applied in more than
50,000 deaths. In 2001, the procedures were further refined
with reference to other existing and recommended tools.
They were then translated with additional slight modifica-
tions for use in the Chinese Disease Surveillance Points
System and vital registration system. The Chinese Disease
Surveillance Points System is China’s national sample vital
registration system, covering 6% of the population in 160
urban and rural clusters [37].
The procedures discussed in this article were the subject of
a 4-y validation study in Tanzania and China. The details of
the study protocol and results for all age groups from both
countries have been published elsewhere [38,39]. Briefly, the
protocol entailed collection of VA and medical record
information for the same individuals. In Tanzania, data were
collected from urban and rural sentinel demographic
surveillance areas operated by the Tanzanian Ministry of
Health through the Adult Morbidity and Mortality Project,
and from nearby health facilities [40]. Deaths from the
sentinel areas were eligible for inclusion if the deceased
visited a health facility during the period during which the
‘‘terminal’’ events leading to the death occurred. This did not
necessarily mean that the death took place in the facility. For
all eligible deaths an attempt was made to trace the medical
records after informed consent was obtained from surviving
family members. For deaths that occurred in participating
health facilities during the study period, all were eligible,
provided they met a geographic restriction criterion to
ensure comparability with deaths from the sentinel surveil-
lance sites [38]. In these cases, the medical records were
obtained from the health facility, and the relatives, if they
gave consent, were traced to their homes, usually within 1 mo
after the death, and a VA interview was administered. In
China, data were collected from urban areas through
collaboration with the national Disease Surveillance Points
System. Deaths were included from 100 tertiary hospitals in
six cities. The number of deaths selected for each cause was
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based on the frequency in the routine system, with over-
sampling of some rarer causes and undersampling of some
very common causes.
Physician panels assigned causes of death to all VAs and
medical records using standard procedures, including blind-
ing. Medical records and VA data were handled identically in
this regard, and both sources were used to produce standard
death certificates. No physician assigned causes of death using
both the VA and medical record for the same individual.
Entries were then coded to ICD-10 at the core code and four-
digit levels and tabulated according to the list in Table 1. The
table contains a 57-item VA tabulation list with ICD-10 core
codes in the third column. The list is organized according to
International Statistical Classification of Diseases (ICD)
principles, and contains the causes that are amenable to
detection by VA and are relevant for guiding policy and
program development. It is important to use such a
tabulation list as a minimum standard for reporting in order
to maintain international comparability of mortality datasets.
Results
Content of Core VA Interview Forms
In order to function well as part of routine systems, the
forms had to be easy to use by interviewers with varying
degrees of clinical skills and knowledge. They were also used
to record relevant contextual information (such as use of
health facilities in the period before death and data on risk
factors). Additionally, the forms made use of any documen-
tary evidence available from the household of the deceased
that might aid in determining the probable cause of death.
Lastly, the forms had to provide physicians with enough data
to produce internationally comparable mortality statistics
based on ICD coding guidelines, and be amenable to
developing data-derived algorithms to determine the prob-
able cause of death [41].
All short core VA forms referred to in this article are
available online. They include the forms for perinatal events
and neonatal deaths (Figure S1), deaths in post-neonatal
children under age 5 (Figure S2), and deaths among persons
aged 5 y and above (Figure S3). Each form follows the same
basic structure: identifying information about the deceased
(including age, sex, and place of death), cause of death
according to respondent, short narrative history, symptom
duration checklist, health services used in the period before
death, and any medical evidence available at the household,
including whether a health worker informed the respondent
of the cause of death.
A section on the condition of the mother during and after
pregnancy and birth is included on the neonatal form. Deaths
to women of reproductive age, and maternal deaths in
particular, are addressed in a subsection of the form for
deaths over age 5. The questions contained in the symptom
duration checklist are generally arranged by anatomical
system. They are intended to provide strong support for a
positive diagnosis of probable cause of death, and the
confident exclusion of differential diagnoses.
Table 2 compares the VA form used at some sites that are
members of the INDEPTH Network [42], the VA form used by
the Indian Sample Registration System (Indian SRS) [15–18],
and a VA form from the WHO [12], and notes key areas of
difference in content. VA interview forms tailored to specific
age groups generally use the same standard cut-off for
neonatal mortality (i.e., death before 28 d), although there is
some variation in the age range for the application of forms
for post-neonatal child deaths [17,42–44]. For reasons of cost
and ease of implementation, the layout and length of the
proposed core forms were limited to no more than two A4-
sized pages. In this they are similar to forms used in the
Indian SRS, and much briefer than most other VA forms
presented in the literature [12,13,41].
Aside from the differences noted in Table 2, the use of long
‘‘open history’’ sections in other forms is another major
difference between the proposed core forms and other
published VA tools. The Indian SRS form for adult deaths,
for example, relies almost exclusively on narrative histories of
the events preceding death to provide evidence about the
cause of death. If administered as a clinical history, these
sections can provide relevant information to physicians who
assign probable causes of death. The short core forms in
Figures S1–S3 allow for brief narrative histories, but
emphasize a ‘‘symptom duration checklist’’ approach for
use in cause-of-death attribution.
Experience in implementing VA procedures suggests that
lengthy clinical history sections cannot be standardized and
vary substantially depending on the clinical skills and medical
training of the interviewer. In addition, interviewers may
introduce bias into data collection by recording histories that
neatly fit into known or familiar disease descriptions or are
based on the interviewers’ initial impressions of the likely
cause of death. Therefore, a core symptom duration checklist
may be more systematic and to produce a more complete
inventory of the signs and symptoms before death than would
a heavier reliance on open histories.
Interviewing Protocols and Cross-Cultural Applicability of
Procedures
A VA interview is conducted similarly to any confidential
health-related interview, with the added consideration that
the subject matter concerns a topic that could hardly be more
distressing—the recent death of a family or household
member. This, in part, speaks to the need to enroll respected
community members in areas where VA will be implemented
to help build local awareness and acceptance of what is,
generally speaking, a new and unfamiliar mechanism of
collecting health information.
There is a range of opinion about whether medical training
should be a preferred qualification for VA interviewers or
whether educated but non-medically trained persons are
more suitable. Local experience will determine the optimal
solution. Training should include discussion of symptoms and
their description in local languages. In addition, a clear
understanding of how live births and stillbirths can be
accurately differentiated using appropriate terminology is
important. Ideally, the interview should happen as soon as
possible after a death with due consideration to culturally
appropriate mourning periods. All questions on the VA form
(aside from the appropriate skips) must be asked of the
respondent regardless of the opinion of the interviewer as to
their relevance. Quality assurance should be performed
routinely. If feasible, re-interview of a 10%–15% sample of
VAs would offer a strict standard. However, given the
sensitive nature of VA, it may be sufficient to verify for a
similar proportion of deaths that (a) the death indeed
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Table 1. ICD Mortality Tabulation List for VA Data
Code ICD Cause Group ICD-10 Code/Ranges
VA:001 Intestinal infectious diseases (including diarrheal diseases) A00–A09
VA:002 Tuberculosis A15–A19
VA:003 Tetanus A33–A35
VA:004 Measles B05
VA:005 Viral hepatitis B15–B19
VA:006 Human immunodeficiency virus (HIV) disease B20–B24
VA:007 Malaria B50–B54
VA:008 Leishmaniasis B55
VA:009 Remainder of infectious and parasitic diseases A20–A28, A30–A32,A36–A38, A40–A49, A50–A64,
A65–A79, A80–A89, A90–A99, B00–B04, B06–B09,
B25–B49, B56–B64, B65–B99
VA:010 Malignant neoplasm of lip, oral cavity, and pharynx C00–C14
VA:011 Malignant neoplasm of esophagus C15
VA:012 Malignant neoplasm of stomach C16
VA:013 Malignant neoplasm of small intestine C17
VA:014 Malignant neoplasm of colon, rectum, and anus C18–C21
VA:015 Malignant neoplasm of liver and intrahepatic bile ducts C22
VA:016 Malignant neoplasm of trachea, bronchus, and lung C33–C34
VA:017 Malignant neoplasm of breast C50
VA:018 Malignant neoplasm of cervix, other, and unspecified parts of uterus C53–C55
VA:019 Remainder of malignant neoplasms C23–C32, C37–C49, C51–C52, C56–C97
VA:020 Nutritional anemias D50–D53
VA:021 Diabetes mellitus E10–E14
VA:022 Malnutrition E40–E46
VA:023 Mental and behavioral disorders F00–F99
VA:024 Meningitis G00, G03
VA:025 Hypertensive diseases I10–I13
VA:026 Ischemic heart diseases I20–I25
VA:027 Cerebrovascular diseases I60–I69
VA:028 Pneumonia J12–J18
VA:029 Chronic obstructive pulmonary diseases J40–J44
VA:030 Gastric and duodenal ulcer K25–K27
VA:031 Cirrhosis of the liver K70–K74
VA:032 Disorders of the kidney N00–N29
VA:033 Pregnancy with abortive outcome O00–O08
VA:034 Hypertensive disorders of pregnancy O10–O16
VA:035 Maternal hemorrhage O44–O46,O70–72
VA:036 Obstructed labor O64–O66
VA:037 Complications predominantly related to the puerperium O85–O92
VA:038 Other maternal causes O20–O43, O47–O63, O67–O69, O73–O84, O95–O99
VA:039 Prematurity and low birth weight P05–P07
VA:040 Birth trauma P10–P15
VA:041 Birth asphyxia, and other respiratory disorders specific to
the perinatal period
P20–P24
VA:042 Stillbirths P95
VA:043 All other conditions originating in the perinatal period P00–P04, P08, P25–P29, P35–P94, P96
VA:044 Congenital malformations of the central nervous system Q00–Q07
VA:045 Abdominal pain R10
VA:046 Fever of unknown origin R50
VA:047 Convulsions, not elsewhere classified R56
VA:048 Unspecified causes of mortality R00:R09, R11:R49, R51:R55, R57:R99
VA:049 All other diseases D00–D48,D55–D89, E00–E07,E15–E34, E50–E88,G04–G98,
H00–H95,I01–I09, I26–I52, I70–I99, J00–J11, J20–J39,
J45–J99,K00–K22, K28–K73, K75–K92, L00–L98, M00–M99,
N30–N98,Q10–Q99
VA:050 Transport accidents V01–V99
VA:051 Falls W00–W19
VA:052 Accidental drowning and submersion W65–W74
VA:053 Exposure to smoke, fire, and flames X00–X09
VA:054 Accidental poisoning by and exposure to noxious substances X40–X49
VA:055 Intentional self-harm X60–X84
VA:056 Assault X85–Y09
VA:057 All other external causes W20–W64, W75–W99, X10–X39, X50–X59, Y10–Y89
DOI: 10.1371/journal.pmed.0030268.t001
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Table 2. Content Comparison of Verbal Autopsy Forms
Proposed
Short
Core
Forms
INDEPTHa Indian SRSb WHO 1999c
Percent Overlap
of Symptom/
Duration
Questions
Comments Percent Overlap
of Symptom/
Duration
Questions
Comments Percent Overlap
of Symptom/
Duration
Questions
Comments
Perinatal–
neonatal (2)d
75% (11) More questions on
short core form
about current health
of mother, circumstances
at birth, stillbirth. More
questions on INDEPTH
form about injury, chronic
illness, malformations,
abdominal swelling,
coldness to touch,
bleeding (open-ended),
diarrhea frequency and
bloodiness, respiratory
function.
79% (2) More questions on
short core form
about antenatal
care, current health
of mother, circumstances
at birth, stillbirth. More
questions on Indian SRS
form about alertness
and consciousness and
duration, suckling prior
to death and duration
of inability to suckle,
duration of terminal
illness, body coldness.
67% (14) More questions on short
core form about condition
of mother, antenatal care,
circumstances surrounding
birth. More question on
WHO form about type of
injury and length of
survival; presentation at
delivery; type of
malformation; duration of
inability to suckle; inability
to cry; did child have
tetanus; quality, frequency,
and bloodiness of diarrhea;
respiratory function and
sound of breathing;
did child have pneumonia.
Post-neonatal
child , 5 (2)
55%e (13) More questions on short
core form about circumstances
at birth, breast feeding,
abdominal and GI conditions,
CNS signs, circulatory/liver
problems. More questions on
INDEPTH form about injury,
chronic illness, growth,
diarrhea frequency and
dehydration/sunken eyes,
quality of cough,
wheezing, grip strength,
alertness, fontanel, skin
and rashes, kwashiorkor
and marasmus, anemia,
lymphatic swelling.
68%f (2) More questions on
short core form about
circumstances at birth,
breast feeding, abdominal
and GI conditions,
CNS signs, circulatory/liver
problems. More questions
on Indian SRS form about
duration of terminal illness,
chills and rigors, wheezing,
location of abdominal pain,
location of rash, symptom
pattern of frequent previous
illness.
49% (15) More questions on
short core form
about circumstances
at birth, breast feeding,
abdominal and GI
conditions, CNS signs,
circulatory/liver problems.
More questions on
WHO form about
survival after injury,
fontanel, skin and rashes,
kwashiorkor and marasmus,
anemia, lymphatic swelling,
grip strength, alertness.
Age 5þ (3) 80% (22) More questions on short
core form about cardiovascular
symptoms, noncommunicable
diseases, female reproductive
health, maternal mortality,
abortion, mouth sores. More
questions on INDEPTH form
about quality of fever,
skin and rash, histamine
reactions, degree of
weight loss, lymphatic
swelling, quality of cough,
night sweats, chest pain
duration, diarrhea and
dehydration/sunken eyes,
vomiting frequency and
appearance, quality and
severity of abdominal pain
and ability to pass stool,
location of abdominal mass,
characteristics of convulsion,
changes in color and difficulty/
pain in urination, surgery in
period before death, antenatal
care, history of pregnancy
complications, injury location
and method of intentional
self-harm.
N/Ag N/A
aSource: [30].
bSource: [31–33].
cSource: [34].
dPage length of forms in parentheses.
eAge group for form: post-neonate to 12 y.
fAge group for form: post-neonate to 14 y.
gN/A: Cause-of-death determination based primarily on open history.
CNS, central nervous system; GI, gastrointestinal.
DOI: 10.1371/journal.pmed.0030268.t002
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occurred and (b) the VA interview in fact took place at the
household of the deceased, with an appropriate respondent.
Interviewer retraining and supportive supervision are prob-
ably the most important components of quality assurance for
VA.
As with any survey instrument intended for cross-cultural
and cross-linguistic application, care must be taken in
translation into local languages and field testing so that all
questions are understood by respondents in the way they are
intended [22]. Part of the cultural validation of VA should
include observations of VA by a medical anthropologist or
sociologist, and interviews with community members to
ensure accurate understanding of terms used in the VA
form. VA interviewers should be informed about any areas of
potential confusion due to local or colloquial expressions.
This will help ensure that in addition to building community
rapport for administering VA, culturally appropriate and
sensitive terms, idioms, and expressions are used in interviews
without sacrificing precision and cross-comparability of
results. A balance must be struck between clinically precise
terminology, which can be confusing or even offensive in the
context of a VA interview, and colloquial expressions or local
terms that might impede accurate cause of death attribution
and ICD coding.
It is also important to consider linguistic and cultural issues
in implementing proposed core VA forms in very different
settings. The experience of transferring these procedures
from Tanzania to China has been instructive in this regard. It
is felt that both the brevity of the interviews and the efforts
expended in establishing rapport contributed to attaining
response rates in both settings of over 90%. Minimal, though
important, modifications were required to translate specific
questions and variables from the original Tanzanian forms
into the Chinese context. For instance, the question ‘‘Was
[the deceased] breathless on lying flat?’’ employed in
Tanzania was not clearly interpreted in China, and a question
on ‘‘breathlessness interfering with sleep’’ was substituted.
Chinese interviewers readily adopted the protocols, and
physician reviewers in both sites were able to certify causes
of death using an international death certificate. Finally,
statistics could be compiled from both countries according to
the proposed tabulation list, yielding internationally com-
parable data.
ICD Coding, Cause-of-Death Attribution, and Tabulation
List
Because VA may serve as the best or even sole evidence on
cause of death in many settings, establishing international
comparability is important [4–6,26,45]. The lack of standard
interview forms, cause-of-death categories, and coding
practices has hindered attempts to synthesize results from
various applications of VA to assessing precise causes of child
mortality [4,6,45]. Therefore, it is recommended that the
causes of death as determined through physician review of
VA be recorded using a four-line death certificate (i.e.,
underlying, immediate, associated, and contributory causes).
Subsequently, a physician or medical recorder should select
and code the underlying cause to the core 3 character code
using standard ICD-10 rules.
In certain cases it may be possible to code to the fourth
digit. On the other hand, ICD-10 rules may frequently
preclude the use of certain three-digit codes in the VA
context. For example, ICD codes starting with B50, B51, and
B52 refer to malaria. Use of these codes requires both
confirmation of parasite infection and identification of the
malaria species. It is unlikely that evidence of such con-
firmation would be available at the household level. In such
instances there are usually three-digit codes available for use
(in this case either ‘‘B53 other parasitologically confirmed
malaria’’ or ‘‘B54 unspecified malaria—clinically diagnosed
malaria without parasitological confirmation’’) that would
not affect the outcome of tabulating and reporting VA data,
or the main public-health interpretations and policy impli-
cations of the tabulated data.
Physicians who review the completed VA forms usually
require training in cause-of-death certification using ICD
rules and international death certificates. An explanation of
the structure and content of the ICD classification, and of the
rules for selection and coding of the underlying cause of
death, is also necessary to ensure uniformity of data across
different coders. Details of coding guidelines and criteria,
manuals, and options for organizing VA coding can be
obtained from the authors.
The issue of reporting single versus multiple causes of
death in VAs, particularly for children, has been addressed
extensively. Most sources recommend or employ multiple
cause-of-death attribution in children without providing a
single underlying cause [43,44,46–48], and at least one source
does so for adults [13]. We recommend the use of standard
death certificates for all ages in accordance with ICD
convention ([32], p. 31). This enables recording, coding, and
analysis of multiple causes of death while retaining compa-
rability of mortality data based on the tabulation of a single
underlying cause, as prescribed by ICD. Although ICD does
recommend a specially designed death certificate for peri-
natal deaths ([32], p. 90), few countries have implemented it.
For the present, therefore, perinatal deaths (and stillbirths, if
desired) may be recorded, together with neonatal deaths, on a
conventional death certificate.
The ICD recommends two ‘‘condensed’’ tabulation lists for
mortality reporting [33]. These lists contain many causes that
can be accurately identified only with specific diagnostic or
clinical information. In the case of VA, the smaller list of
causes presented in Table 1 is more appropriate. The ICD
specifically sanctions the development of such tailored
tabulation lists [32].
Validation and Comparative Findings from China and
Tanzania in Deaths over Age 5
There were 25 causes in China and 26 causes in Tanzania
(for at least one age group) for which there were at least five
deaths in both the VA and the medical records. Table 3 shows
summary results for causes of death for which at least five
deaths were validated, sensitivity was greater than 50%, and
the relative difference in the cause-specific mortality fraction
(CSMF) in the VA (CSMFVA) and medical record (CMFSMR)
was equal to or less than 20%. These criteria are based on
threshold values for sensitivity and CSMF suggested for
assessing accuracy of adult VA [49]. The comparison of
CSMFs was based on the relative difference in the proportion
of deaths due to cause X in the medical records dataset
(CSMFMR) from the proportion of deaths due to the same
cause in the verbal autopsy dataset (CSMFVA). We calculated
sensitivities and specificities for all causes using conventional
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two-by-two table analysis, although results are displayed only
for those causes reaching the threshold sensitivity. For the
over-five age group, data were available for 1,912 deaths in 42
cause-of-death categories from Tanzania, and 2,029 deaths in
37 categories from rural areas in China. Of these, 140 deaths
from Tanzania and 170 deaths from China were coded to
either ‘‘all other specified diseases’’ or ‘‘undetermined’’; these
are excluded from the comparison.
Of the 20 causes of death listed in Table 3, three (VA-02
tuberculosis, VA-27 cerebrovascular diseases, and VA-50
transport accidents) met the threshold criteria in both
countries. Six causes reached the threshold in Tanzania only,
and 11 causes met the threshold levels in China only. At the
upper bound of the 95% confidence level for sensitivity,
seven additional causes reach the threshold in Tanzania (VA-
09 remainder of infectious and parasitic diseases, VA-15
malignant neoplasm of liver, VA-19 other neoplasms, VA-21
diabetes mellitus, VA-25 hypertensive diseases, VA-38 other
maternal causes, and VA-57 all other external causes).
Significantly, for six causes (VA-09 remainder of infectious
and parasitic diseases, VA-17 malignant neoplasm of breast,
VA-21 diabetes mellitus, VA-25 hypertensive diseases, VA-29
asthma/chronic obstructive pulmonary disease, and VA-51
falls) the relative difference in sensitivity of VA was less than
25%. It should be born in mind that because of the small
samples for certain causes of death it was not possible in the
studies to validate all the causes contained in Table 1.
Discussion
The increasing importance of VA is reflected in the
growing number of meta-analyses of VA-based datasets on
child mortality from demographic surveillance sites and
special studies [4–6,45], all of which make the case for
standardized procedures. The procedures presented here are
the product of over a decade of application, trial, assessment,
and refinement, and have considerable commonalities with
other forms in the public domain.
The main purpose of these tools is to supply countries that
have no source of reliable mortality reporting and cause-of-
death data with the means to confidently produce and use
accurate, repeatable, and internationally comparable meas-
urements of the cause structure of mortality for the most
important diseases and conditions, and that are free from
major systematic misclassification. To be sure, VA is a crude
substitute for proper medical certification of cause of
death—which can be a dubious ‘‘gold standard’’ even in
developed countries [50]. The Tanzania–China experience
has shown that the transfer of this technology from one
setting to another is feasible and can produce results with
acceptable sensitivity and CSMFs for important causes of
death. In wider application, local validation studies should be
considered an essential part of implementing VA procedures
intended for national monitoring, evaluation, priority-set-
ting, and policy-making.
These VA procedures performed quite differently for
different causes in China and Tanzania. In Tanzania, where
more data were available to analyze VA performance in
younger age groups (analysis not presented), VA yielded good
sensitivity, specificity, and CSMFs for several important causes
including pneumonia, but did not perform as well for others,
including childhood malaria. This re-emphasizes the need to
bear in mind previous findings that both the number of
different causes and their underlying prevalence vary by age
and across settings where the use VA procedures is appro-
priate, and that this variation affects VA performance
[19,51,52]. Thus, wherever feasible, VA procedures should be
accompanied by a validation study, and revalidation should be
undertaken periodically if there are indications of major shifts
in causes of mortality—either as a result of successful large-
scale intervention, or due to epidemics. Validation studies
should also take into consideration that the ‘‘gold standard’’ of
medical record diagnosis is often an imperfect one, at best. A
carefully conducted VAmay be superior to poorly maintained
or scanty medical records, as seen, for example, in stillbirth
[53]. It should also be acknowledged that for some conditions,
such as malaria mortality among adults, for which no reliable
statistics exist, neither VA nor medical records may form a
suitable evidence base.
In addition to the use of standard procedures, the following
are needed in order to make the best informed use of VA:
further validation studies for less prevalent causes and
whenever the procedures are applied in a new setting, further
investigation into the effect of recall period [54] and
respondent characteristics (e.g., relationship to the deceased
and education), further development of guidelines and
criteria for assigning cause of death, systematic handling of
misclassification error, and candor with respect to any
insuperable limitations of VA [14,19]. The WHO’s leadership
Table 3. Validation Results for Causes of Adult Mortality in
Tanzania and China
Country Cause of Deatha
Tanzania and China
(nTanzania /nChina)
VA-02 tuberculosis (158/45)
VA-27 cerebrovascular diseases (91/369)
VA-50 transport accidents (10/30)
Tanzania only (n) VA-01 intestinal infectious diseases
(including diarrhea) (34)
VA-06 human immunodeficiency virus (HIV)
disease (610)
VA-07 malaria (334)
VA-11 malignant neoplasm of esophagus (13)
VA-34 hypertensive disorders of pregnancy (9)
VA-35 maternal hemorrhage (7)
China only (n) VA-12 malignant neoplasm of stomach (68)
VA-14 malignant neoplasm of colon, rectum,
and anus (68)
VA-15 malignant neoplasm of liver (212)
VA-16 malignant neoplasm of trachea,
bronchus, and lung (102)
VA-17 malignant neoplasm of breast (18)
VA-19 other neoplasms (95)
VA-20 anemia (16)
VA-21 diabetes mellitus (81)
VA-26 ischemic heart diseases (206)
VA-44 congenital malformations (6)
VA-51 falls (21)
Causes of death reported met the following criteria: sensitivity . 50%, and relative
difference of 620% between CSMFVA and CSMFMR.
aCauses of adult death not validated: VA-04, VA-08, VA-13, VA-33, VA-36, VA-37; VA-45–
VA-49, and VA-52 (see Table 1).
DOI: 10.1371/journal.pmed.0030268.t003
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in the future development of VA procedures will be critical to
establishing international standards.
Even with extensive validation, the weight given to VA-
derived mortality data is likely to be an ongoing topic of
debate. Ultimately, the interpretation of how well VA
performs is entirely dependent upon the function the
technique is meant to perform. VA will never meet the
standards of proper medical certification of death at the time
of its occurrence. The technique has inherent shortcomings
including the prevalence dependency of its accuracy, and the
serious effects that variations in sensitivity and specificity can
have on comparative estimates of cause-specific mortality
across populations or over time in the same population
[19,51]. Nevertheless, for purposes of broad priority-setting,
tracking trends in mortality due to major conditions of
public-health importance, and providing broad burden-of-
disease measures, it may be deemed preferable to the current
state of near ignorance with regard to direct measures of
cause-specific mortality, particularly among adults.
Standard and validated VA procedures are only part of the
solution to maximal utility of VA. It is critical to do validation
studies so that the degree of uncertainty, which will vary by
cause of death, can be factored into mortality burden
estimations. While the use of proportional mortality models
based on VA data to estimate mortality burdens [4,6,45]
remains controversial, these models have the virtue of
attempting to make use of the only body of data available
on cause-specific mortality for the populations concerned.
More significant progress in producing mortality statistics
that are valid, comparable, and representative, however, will
depend on an expanded commitment to sample vital
registration systems that use VA—not through reliance on
disease-specific research studies, household surveys, or
research demographic surveillance systems. Future research
will allow a better understanding of the degree to which these
core tools, with locally appropriate modifications, can
achieve the ultimate aim of generating reliable and interna-
tionally comparable cause-specific mortality statistics.
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Editors’ Summary
Background. People living in developed countries take it for granted
that when a loved one dies an accurate cause-of-death certificate will be
issued. But for two-thirds of the deaths that occur worldwide, there are
no certificates. Detailed information about what people die from is
unavailable for more than 50% of countries, many of which have high
death rates. This information is badly needed for public-health planning,
for using scarce health resources wisely, and for monitoring the effect of
new health initiatives. One way to improve knowledge about what
people die from is a procedure called verbal autopsy (VA). Relatives or
caregivers are interviewed about the symptoms experienced by the
deceased before their death and the circumstances surrounding their
death by trained personnel who use a standard form. Doctors then
review the completed VA forms and assign a specific cause of death from
a short version of the International Classifications of Diseases, or ICD, an
internationally agreed on list of codes for hundreds of diseases.
Why Was This Study Done? VA procedures are being developed in
many countries, but each step in a VA can be affected by factors that
vary from place to place, such as how long after the death the interview
is done, the training that interviewers receive, how the questions are
worded, and the locally common diseases, which tend to be recognized
better than rare diseases. To ensure that the data collected are accurate
and comparable between countries and also over time, VA procedures
need to be standardized. In this study, the researchers describe their
efforts to achieve this through the development and validation of core
VA procedures.
What Did the Researchers Do and Find? In 2001, the researchers
refined the VA forms that were being used in Tanzania for deaths
occurring around the time of birth and for deaths occurring in childhood
and adulthood. They then translated the forms for use in China, adapting
them slightly to allow for cultural differences in how symptoms are
described. They also drew up a short list of ICD codes to use in
tabulating and validating important causes of death. Then, for four years,
they collected VA and medical record information for the same deceased
individuals and measured how well the VA procedure agreed with the
medical record information in both countries. They found that the
procedure could be transferred between China and Tanzania but that it
performed rather differently for different causes of death in the two
countries. So, in both countries, the procedure accurately recorded
tuberculosis, cerebrovascular diseases such as strokes, and transport
accidents as causes of death. But some other causes of death were
accurately recorded in one country only—generally the common
diseases in that country—and many causes of death were inaccurately
reported in both countries.
What Do These Findings Mean? The researchers use their experience of
developing VAs for use in Tanzania and China and the results of this
study to make several recommendations about how to develop
standardized VA procedures that will yield accurate cause of death. For
example, they suggest that the VA form should contain a detailed core
symptom duration checklist and only a short space for a narrative history
(an open-ended description of the last illness provided by the relative or
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caregiver) because long narrative histories are hard to standardize. They
discuss the need to adapt core VA forms whenmoving between countries
to allow for linguistic differences and colloquial expression and also the
need to consider cultural differences between countries—for example,
how soon after bereavement a VA interview can occur. Most importantly,
they strongly recommend that validation studies like theirs should be
routinely done when VA procedures are applied in new countries or if the
major cause of death in a country changes because of a new epidemic or
health initiative. Provided this is done, write the researchers, although VA
procedures can never be as accurate as proper medical certification at the
time of death, they should provide important information about the
causes of death for the many countries where this information would
otherwise be completely missing.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0030268.
 World Health Organization information on mortality and on the
International Classification of Diseases
 The United Nations’ World Mortality Report 2005
 Information on the Tanzania Ministry of Health Adult Morbidity and
Mortality Project, which used the VA procedures on which this study
was based
 A description of a standard VA method for investigating deaths in
infants and children from the World Health Organization
 The INDEPTH Network, an organization collecting health statistics from
developing countries that provides standardized VA forms
 MEASURE Evaluation, a USAID-funded project that, in collaboration
with the US Census Bureau and the University of Queensland (Australia),
supports countries to implement core VA procedures and sample/
sentinel vital registration methods
 The Health Metrics Network, a global collaboration focused on
strengthening country health information systems to generate sound
data for decision-making at country and global levels, is committed to
improving sources of vital statistics and cause-of-death data
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